Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ruxolitinib”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07025538
What this trial is testing

Biomarker-Guided Ruxolitinib for the Prevention of Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Hematopoietic and Lymphatic System Neoplasm
City of Hope Medical Center 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT03286530
What this trial is testing

Ruxolitinib + Allogeneic Stem Cell Transplantation in AML

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia in RemissionAllogeneic Stem Cell Transplantation
Massachusetts General Hospital 64
Testing effectiveness (Phase 2)Study completedNCT03773107
What this trial is testing

LCI-HEM-MYE-CRD-004 (MMRC-073 CARJAK): Study of CRD for Carfilzomib-Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Wake Forest University Health Sciences 12
Testing effectiveness (Phase 2)Ended earlyNCT02718300
What this trial is testing

INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis

Who this might be right for
MPN (Myeloproliferative Neoplasms)
Incyte Corporation 74
Testing effectiveness (Phase 2)Study completedNCT00639002
What this trial is testing

Determine the Effect and Safety of an Oral Janus Kinase 2 (JAK2)-Inhibitor (Ruxolitinib; INBC018424) in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Incyte Corporation 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT03333187
What this trial is testing

Ruxolitinib vs Allogeneic SCT for Patients With Myelofibrosis According to Donor Availability

Who this might be right for
Bone Marrow Fibrosis
Universitätsklinikum Hamburg-Eppendorf 87
Early research (Phase 1)Active Not RecruitingNCT06768476
What this trial is testing

CART123 + Ruxolitinib in Relapsed/Refractory AML

Who this might be right for
Relapsed AMLRefractory AML
University of Pennsylvania 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT06752694
What this trial is testing

Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell Transplantation in Older Adult Patients With Acquired Aplastic Anemia

Who this might be right for
Aplastic Anemia
Fred Hutchinson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT05635838
What this trial is testing

Study to Evaluate of the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa

Who this might be right for
Hidradenitis Suppurativa
Incyte Corporation 69
Testing effectiveness (Phase 2)Active Not RecruitingNCT03069326
What this trial is testing

A Clinical Study to Test the Effects of Ruxolitinib And Thalidomide Combination for Patients With Myelofibrosis

Who this might be right for
Myelofibrosis
Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT01445769
What this trial is testing

Alternative Dosing Strategy of Ruxolitinib in Patients With Myelofibrosis

Who this might be right for
Primary MyelofibrosisPost-Polycythemia Vera MyelofibrosisPost-Essential Thrombocythemia Myelofibrosis
Incyte Corporation 45
Testing effectiveness (Phase 2)Ended earlyNCT04414514
What this trial is testing

Topical Ruxolitinib 1.5% for Hidradenitis Suppurativa Treatment

Who this might be right for
Hidradenitis Suppurativa
Milton S. Hershey Medical Center 6
Testing effectiveness (Phase 2)Looking for participantsNCT06887803
What this trial is testing

Roginolisib in Combination With Ruxolitinib in Patients With Myelofibrosis (MF) Who Are Unresponsive to JAK Inhibitors

Who this might be right for
Myelofibrosis (MF)
iOnctura 26
Early research (Phase 1)Ended earlyNCT06388759
What this trial is testing

TQ05105 Tablet for Myelofibrosis Treatment in Ruxolitinib-Resistant or Intolerant Patients

Who this might be right for
Myelofibrosis
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 9
Early research (Phase 1)Study completedNCT02960945
What this trial is testing

Open-Label Crossover Study Comparing CTP-543 to Jakafi®

Who this might be right for
Healthy
Concert Pharmaceuticals 12
Testing effectiveness (Phase 2)WithdrawnNCT06619522
What this trial is testing

INCB57643 (BET Inhibitor) in Combination With Ruxolitinib in JAK Inhibitor-naïve Patients With Myelofibrosis

Who this might be right for
Myelofibrosis
M.D. Anderson Cancer Center
Large-scale testing (Phase 3)Ended earlyNCT04551053
What this trial is testing

To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304)

Who this might be right for
MyelofibrosisPrimary MyelofibrosisPost Essential Thrombocythemia Myelofibrosis+1 more
Incyte Corporation 177
Testing effectiveness (Phase 2)Study completedNCT00617994
What this trial is testing

Open Label, Safety and Efficacy Study of Topical Investigational Drug to Treat Patients With Psoriasis

Who this might be right for
Psoriasis
Incyte Corporation 25
Testing effectiveness (Phase 2)Looking for participantsNCT06345495
What this trial is testing

High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly

Who this might be right for
SplenomegalyMyelofibrosis
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT01431209
What this trial is testing

Ruxolitinib Phosphate to Treat Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma After Stem Cell Transplant

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent Mature T- and NK-Cell Non-Hodgkin LymphomaRefractory Diffuse Large B-Cell Lymphoma+1 more
University of Nebraska 71
Next Page